The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
Authors
Keywords
-
Journal
PLoS One
Volume 12, Issue 6, Pages e0173593
Publisher
Public Library of Science (PLoS)
Online
2017-06-07
DOI
10.1371/journal.pone.0173593
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discordance inHER2gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer
- (2013) Savitri Krishnamurthy et al. Cancer Medicine
- Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
- (2012) V. Georgoulias et al. ANNALS OF ONCOLOGY
- Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
- (2012) François-Clément Bidard et al. CANCER AND METASTASIS REVIEWS
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
- (2011) J.- Y. Pierga et al. ANNALS OF ONCOLOGY
- HER2 genetic heterogeneity in breast carcinoma
- (2011) C. Ohlschlegel et al. JOURNAL OF CLINICAL PATHOLOGY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- HER2-Positive Circulating Tumor Cells in Breast Cancer
- (2011) Michail Ignatiadis et al. PLoS One
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer
- (2010) Elisabetta Munzone et al. Clinical Breast Cancer
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
- (2009) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
- (2009) Marta Pestrin et al. BREAST CANCER RESEARCH AND TREATMENT
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
- (2009) Nikolaos Xenidis et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
- (2008) Julie E. Lang et al. BREAST CANCER RESEARCH AND TREATMENT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started